1 Adams HP Jr，Bendixen BH，Kappelle LJ，et

al. Classif ication of subtype of acute ischemic

stroke. Definitions for use in a multicenter clinical

trial. TOAST. Trial of Org 10 172 in Acute Stroke

Treatment[J]. Stroke，1993，24：35-41.

2 Alvarez-Garcia I，Miska EA. MicroRNA functions

in animal development and human disease[J].

Development，2005，132：4653-1662.

3 Li Y，Kowdley KV. Method for microRNA isolation

from clinical serum samples[J]. Anal Biochem，2012，

431：69-75.

4 Ito T，Yagi S，Yamakuchi M. MicroRNA-34a

regulation of endothelial senescence[J]. Biochem

Biophys Res Commun，2010，398：735-740.

5 Cordes KR，Sheehy NT，White MP，et al. miR-145

and miR-143 regulate smooth muscle cell fate and

plasticity[J]. Nature，2009，460：705-710.

6 Li T，Morgan MJ，Choksi S，et al. MicroRNAs

modulate the noncanonical transcription factor

NF-kappaB pathway by regulating expression

of the k inase IKKalpha dur ing macrophage

differentiation[J]. Nat Immunol，2010，11：799-805.

7 Wang S，Aurora AB，Johnson BA，et al. The

endothelial-specific microRNA miR-126 governs

vascular integrity and angiogenesis[J]. Dev Cell，2008，

15：261-271.

8 Rayner KJ，Suárez Y，Dávalos A，et al. MiR-

33 cont ributes to the regulation of cholesterol

homeostasis[J]. Science，2010，328：1570-1573.

9 Hergenreider E，Heydt S，Trég ue r K，e t a l .

Atheroprotective communication between endothelial

cells and smooth muscle cells through miRNAs[J].

Nat Cell Biol，2012，14：249-256.

10 Ruan W，Xu JM，Li SB，et al. Effects of downregulation

of microRNA-23a on TNF-α-induced

endothelial cell apoptosis though caspase-dependent

pathways[J]. Cardiovasc Res，2012，93：623-632.

11 Long G，Wang F，Li H，et al. Circulating miR-30a，

miR-126 and let-7b as biomarker for ischemic stroke

in humans[J]. BMC Neurol，2013，13：178.

12 Git A，Dvinge H，Salmon-Divon M，et al. Systematic

comparison of microarray profiling，real-time PCR，

and next-generation sequencing technologies for

measuring differential microRNA expression[J]. RNA，

2010，16：991-1006.

13 Tang HM，Chen H，Zhang J，et al. Application of

next generation sequencing in microRNA detection[J].

Yi Chuan，2012，34：784-792.

14 仲倩维，马爱军，潘旭东，等. 缺血性卒中不同亚型患

者血浆miRNAs表达谱变化分析[J]. 中华神经科杂志，

2015，48：114-119.

15 杨淑娜，马爱军，潘旭东，等. 无症状性脑动脉硬化与

大动脉粥样硬化性卒中患者血浆微小RNA表达分析

[J]. 中国卒中杂志，2015，10：120-127.

16 Go l l e d g e J，McCa n n M，Manga n S，e t a l .

Osteoprotegerin and osteopontin are expressed at

high concentrations within symptomatic carotid

atherosclerosis[J]. Stroke，2004，35：1636-1641.

17 Sandberg WJ，Yndestad A，Øie E，et al. Enhanced

T-cell expression of RANK ligand in acute coronary

syndrome：possible role in plaque destabilization[J].

Arterioscler Thromb Vasc Biol，2006，26：857-863.

18 庞萌，潘旭东，马爱军，等. 骨保护素、可溶性核因

子-κB受体活化因子配体与大动脉粥样硬化型卒中及

预后的关系[J]. 中华神经科杂志，2015，48：288-290.

19 Wunderlich MT，Wallesch CW，Goertler M. Release

of neurobiochemical markers of brain damage is

related to the neurovascular status on admission

and the site of arterial occlusion in acute ischemic

stroke[J]. J Neurol Sci，2004，227：49-53.

20 Park SY，Kim MH，Kim OJ，et al. Plasma hearttype

fatty acid binding protein level in acute ischemic

stroke：comparative analysis with plasma S100B level

for diagnosis of stroke and prediction of long-term

clinical outcome[J]. Clin Neurol Neurosurg，2013，115：

405-410.

21 Dassan P，Keir G，Brown MM. Criteria for a clinically

informative serum biomarker in acute ischaemic

stroke：a review of S100B[J]. Cerebrovasc Dis，2009，

27：295-302.

22 Sangiorgi G，Maur iel lo A，Bonanno E，et al.

Pregnancy-associated plasma protein-a is markedly

expressed by monocyte-macrophage cel ls in

vulnerable and ruptured carotid atherosclerotic plaques：

a link between inf lammation and cerebrovascular

events[J]. J Am Coll Cardiol，2006，47：2201-2211.

23 Heider P，Pfäff le N，Pelisek J，et al. Is serum

pregnancy-associated plasma protein A really a

potential marker of atherosclerotic carotid plaque

stability?[J]. Eur J Vasc Endovasc Surg，2010，39：

668-675.

24 Reynolds MA，Kirchick HJ，Dahlen JR，et al. Early

biomarkers of stroke[J]. Clin Chem，2003，49：1733-

1739.

25 Ramos-Fernandez M，Bellolio MF，Stead LG. Matrix

metalloproteinase-9 as a marker for acute ischemic

stroke：a systematic review[J]. J Stroke Cerebrovasc

Dis，2011，20：47-54.

26 Zirlik A，Maier C，Gerdes N，et al. CD40 ligand

mediates inflammation independently of CD40 by

interaction with Mac-1[J]. Circulation，2007，115：

1571-1580.

27 Hocher B，Liefeldt L，Quaschning T，et al. Soluble

CD154 is a unique predictor of nonfatal and fatal

atherothrombotic events in patients who have endstage

renal disease and are on hemodialysis[J]. J Am

Soc Nephrol，2007，18：1323-1330.

28 Martin MM，Buckenberger JA，Jiang J，et al. The

human angiotensin Ⅱ type 1 receptor +1166 A/C

polymorphism attenuates microRNA-155 binding[J]. J

Biol Chem，2007，282：24 262-24 269.

29 Liu DZ，Tian Y，Ander BP，Xu H，et al. Brain and

blood microRNA expression profiling of ischemic

st roke，int racerebral hemorrhage，and kainate

seizures[J]. J Cereb Blood Flow Metab，2010，30：92-

101.

30 Ne z u T，Hosomi N，Aok i S，et a l. A lpha2-macroglobulin as a promising biomarker for cerebral

small vessel disease in acute ischemic st roke

patients[J]. J Neurol，2013，260：2642-2649.

31 张璋，马爱军，潘旭东，等. 血浆α2巨球蛋白水平与小

动脉闭塞型脑梗死发病及认知功能的关系[J]. 中华神

经医学杂志，2015，14：483-486.

32 Lu CH，Hwang CW，Chen NF，et al. Association of

intercellular adhesion molecular-1 gene polymorphism

in ischemic stroke patients[J]. Ann Indian Acad

Neurol，2013，16：380-383.

33 Montaner J，Perea-Gainza M，Delgado P，et al.

Etiologic diagnosis of ischemic stroke subtypes with

plasma biomarkers[J]. Stroke，2008，39：2280-2287.

34 Park L，Raman KG，Lee KJ，et al. Suppression of

accelerated diabetic atherosclerosis by the soluble

receptor for advanced glycation endproducts[J]. Nat

Med，1998，4：1025-1031.

35 Montaner J，Perea-Gainza M，Delgado P，et al.

Etiologic diagnosis of ischemic stroke subtypes with

plasma biomarkers[J]. Stroke，2008，39:2280-2287.